Transabdominal ultrasound is the one of the most widely used imaging modality for initial imaging of patients diagnosed with liver diseases such as Hepatitis C virus and non-alcoholic fatty liver disease. However, current imaging processes cannot differentiate simple steatosis, nonalcoholic steatohepatitis, and hepatic fibrosis.
Researchers at Rutgers University developed a novel method for the extraction of local phase image features from liver and kidney ultrasound data for the enhancement of medical image data. The invention enables a high level of visual clarity allowing a medical practitioner to make a diagnosis based solely on ultrasound data and without the need of biopsy samples. This software is cohesive with current ultrasound technology for facilitated integration.
- Medical devices
- Medical imaging
- Allows for earlier detection
- Enhances raw signals
- Eliminates the need for biopsies
- Easily integrated into current ultrasound machines
Intellectual Property & Development Status:
- Patent pending.
- Available for licensing and/or research collaboration.